Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Association Between Early Hypertension Control and Cardiovascular Disease Incidence in Veterans With Diabetes.

Raghavan S, Ho YL, Kini V, Rhee MK, Vassy JL, Gagnon DR, Cho K, Wilson PWF, Phillips LS.

Diabetes Care. 2019 Oct;42(10):1995-2003. doi: 10.2337/dc19-0686.

PMID:
31515207
2.

Random plasma glucose predicts the diagnosis of diabetes.

Rhee MK, Ho YL, Raghavan S, Vassy JL, Cho K, Gagnon D, Staimez LR, Ford CN, Wilson PWF, Phillips LS.

PLoS One. 2019 Jul 19;14(7):e0219964. doi: 10.1371/journal.pone.0219964. eCollection 2019.

3.

Fried food consumption and risk of coronary artery disease: The Million Veteran Program.

Honerlaw JP, Ho YL, Nguyen XT, Cho K, Vassy JL, Gagnon DR, O'Donnell CJ, Gaziano JM, Wilson PWF, Djousse L; VA Million Veteran Program.

Clin Nutr. 2019 Jun 5. pii: S0261-5614(19)30219-5. doi: 10.1016/j.clnu.2019.05.008. [Epub ahead of print]

4.

The Responsibility to Recontact Research Participants after Reinterpretation of Genetic and Genomic Research Results.

Bombard Y, Brothers KB, Fitzgerald-Butt S, Garrison NA, Jamal L, James CA, Jarvik GP, McCormick JB, Nelson TN, Ormond KE, Rehm HL, Richer J, Souzeau E, Vassy JL, Wagner JK, Levy HP.

Am J Hum Genet. 2019 Apr 4;104(4):578-595. doi: 10.1016/j.ajhg.2019.02.025. Review.

5.

Omega-3 supplement use, fish intake, and risk of non-fatal coronary artery disease and ischemic stroke in the Million Veteran Program.

Ward RE, Cho K, Nguyen XT, Vassy JL, Ho YL, Quaden RM, Gagnon DR, Wilson PWF, Gaziano JM, Djoussé L; VA Million Veteran Program.

Clin Nutr. 2019 Mar 13. pii: S0261-5614(19)30118-9. doi: 10.1016/j.clnu.2019.03.005. [Epub ahead of print]

PMID:
30914216
6.

Palbociclib and Fulvestrant in Breast Cancer.

McCaw ZR, Vassy JL, Wei LJ.

N Engl J Med. 2019 Feb 21;380(8):796. doi: 10.1056/NEJMc1816595. No abstract available.

PMID:
30789681
7.

Diabetes Mellitus-Related All-Cause and Cardiovascular Mortality in a National Cohort of Adults.

Raghavan S, Vassy JL, Ho YL, Song RJ, Gagnon DR, Cho K, Wilson PWF, Phillips LS.

J Am Heart Assoc. 2019 Feb 19;8(4):e011295. doi: 10.1161/JAHA.118.011295.

8.

Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.

Hart MR, Biesecker BB, Blout CL, Christensen KD, Amendola LM, Bergstrom KL, Biswas S, Bowling KM, Brothers KB, Conlin LK, Cooper GM, Dulik MC, East KM, Everett JN, Finnila CR, Ghazani AA, Gilmore MJ, Goddard KAB, Jarvik GP, Johnston JJ, Kauffman TL, Kelley WV, Krier JB, Lewis KL, McGuire AL, McMullen C, Ou J, Plon SE, Rehm HL, Richards CS, Romasko EJ, Sagardia AM, Spinner NB, Thompson ML, Turbitt E, Vassy JL, Wilfond BS, Veenstra DL, Berg JS, Green RC, Biesecker LG, Hindorff LA.

Genet Med. 2019 May;21(5):1261-1262. doi: 10.1038/s41436-019-0440-2.

PMID:
30670880
9.

Response to Gammal et al.

Vassy JL, Stone A, Callaghan JT, Mendes M, Meyer LJ, Pratt VM, Przygodzki RM, Scheuner MT, Wang-Rodriguez J, Schichman SA; VHA Clinical Pharmacogenetics Subcommittee.

Genet Med. 2019 Aug;21(8):1888-1889. doi: 10.1038/s41436-018-0422-9. Epub 2019 Jan 12. No abstract available.

PMID:
30635623
10.

Reconciling Opportunistic and Population Screening in Clinical Genomics.

Brothers KB, Vassy JL, Green RC.

Mayo Clin Proc. 2019 Jan;94(1):103-109. doi: 10.1016/j.mayocp.2018.08.028. Review.

PMID:
30611438
11.

Estimated Filtration: The Continued Need for Expert Classification of Genetic Variants.

Vassy JL.

Ann Intern Med. 2019 Jan 1;170(1):64-65. doi: 10.7326/M18-3090. Epub 2018 Nov 27. No abstract available.

PMID:
30477012
12.

A phenotyping algorithm to identify acute ischemic stroke accurately from a national biobank: the Million Veteran Program.

Imran TF, Posner D, Honerlaw J, Vassy JL, Song RJ, Ho YL, Kittner SJ, Liao KP, Cai T, O'Donnell CJ, Djousse L, Gagnon DR, Gaziano JM, Wilson PW, Cho K.

Clin Epidemiol. 2018 Oct 16;10:1509-1521. doi: 10.2147/CLEP.S160764. eCollection 2018.

13.

The Integrating Pharmacogenetics in Clinical Care (I-PICC) Study: Protocol for a point-of-care randomized controlled trial of statin pharmacogenetics in primary care.

Vassy JL, Brunette CA, Majahalme N, Advani S, MacMullen L, Hau C, Zimolzak AJ, Miller SJ.

Contemp Clin Trials. 2018 Dec;75:40-50. doi: 10.1016/j.cct.2018.10.010. Epub 2018 Oct 24.

PMID:
30367991
14.

Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.

Hart MR, Biesecker BB, Blout CL, Christensen KD, Amendola LM, Bergstrom KL, Biswas S, Bowling KM, Brothers KB, Conlin LK, Cooper GM, Dulik MC, East KM, Everett JN, Finnila CR, Ghazani AA, Gilmore MJ, Goddard KAB, Jarvik GP, Johnston JJ, Kauffman TL, Kelley WV, Krier JB, Lewis KL, McGuire AL, McMullen C, Ou J, Plon SE, Rehm HL, Richards CS, Romasko EJ, Miren Sagardia A, Spinner NB, Thompson ML, Turbitt E, Vassy JL, Wilfond BS, Veenstra DL, Berg JS, Green RC, Biesecker LG, Hindorff LA.

Genet Med. 2019 May;21(5):1100-1110. doi: 10.1038/s41436-018-0308-x. Epub 2018 Oct 5. Erratum in: Genet Med. 2019 Jan 22;:.

PMID:
30287922
15.

Impact of SLCO1B1 Pharmacogenetic Testing on Patient and Healthcare Outcomes: A Systematic Review.

Vassy JL, Chun S, Advani S, Ludin SA, Smith JG, Alligood EC.

Clin Pharmacol Ther. 2019 Aug;106(2):360-373. doi: 10.1002/cpt.1223. Epub 2018 Oct 18. Review.

PMID:
30137643
16.

Pharmacogenetic testing in the Veterans Health Administration (VHA): policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee.

Vassy JL, Stone A, Callaghan JT, Mendes M, Meyer LJ, Pratt VM, Przygodzki RM, Scheuner MT, Wang-Rodriguez J, Schichman SA; VHA Clinical Pharmacogenetics Subcommittee.

Genet Med. 2019 Feb;21(2):382-390. doi: 10.1038/s41436-018-0057-x. Epub 2018 Jun 1.

17.

Toward greater understanding of patient decision-making around genome sequencing.

Hull LE, Vassy JL.

Per Med. 2018 Jan;15(1):57-66. doi: 10.2217/pme-2017-0037.

PMID:
29714114
18.

Erratum. Polygenic Type 2 Diabetes Prediction at the Limit of Common Variant Detection. Diabetes 2014;63:2172-2182.

Vassy JL, Hivert MF, Porneala B, Dauriz M, Florez JC, Dupuis J, Siscovick DS, Fornage M, Rasmussen-Torvik LJ, Bouchard C, Meigs JB.

Diabetes. 2018 Jun;67(6):1206. doi: 10.2337/db18-er06a. Epub 2018 Apr 18. No abstract available.

19.

Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings: a pilot randomized trial.

Christensen KD, Vassy JL, Phillips KA, Blout CL, Azzariti DR, Lu CY, Robinson JO, Lee K, Douglas MP, Yeh JM, Machini K, Stout NK, Rehm HL, McGuire AL, Green RC, Dukhovny D; MedSeq Project.

Genet Med. 2018 Dec;20(12):1544-1553. doi: 10.1038/gim.2018.35. Epub 2018 Mar 22.

20.

How Primary Care Providers Talk to Patients about Genome Sequencing Results: Risk, Rationale, and Recommendation.

Vassy JL, Davis JK, Kirby C, Richardson IJ, Green RC, McGuire AL, Ubel PA.

J Gen Intern Med. 2018 Jun;33(6):877-885. doi: 10.1007/s11606-017-4295-4. Epub 2018 Jan 26.

21.

Yield and bias in defining a cohort study baseline from electronic health record data.

Vassy JL, Ho YL, Honerlaw J, Cho K, Gaziano JM, Wilson PWF, Gagnon DR.

J Biomed Inform. 2018 Feb;78:54-59. doi: 10.1016/j.jbi.2017.12.017. Epub 2018 Jan 3.

22.

Six-Year Diabetes Incidence After Genetic Risk Testing and Counseling: A Randomized Clinical Trial.

Vassy JL, He W, Florez JC, Meigs JB, Grant RW.

Diabetes Care. 2018 Mar;41(3):e25-e26. doi: 10.2337/dc17-1793. Epub 2018 Jan 5. No abstract available.

23.

When bins blur: Patient perspectives on categories of results from clinical whole genome sequencing.

Jamal L, Robinson JO, Christensen KD, Blumenthal-Barby J, Slashinski MJ, Perry DL, Vassy JL, Wycliff J, Green RC, McGuire AL.

AJOB Empir Bioeth. 2017 Apr-Jun;8(2):82-88. doi: 10.1080/23294515.2017.1287786. Epub 2017 Jan 27.

24.

The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial.

Vassy JL, Christensen KD, Schonman EF, Blout CL, Robinson JO, Krier JB, Diamond PM, Lebo M, Machini K, Azzariti DR, Dukhovny D, Bates DW, MacRae CA, Murray MF, Rehm HL, McGuire AL, Green RC; MedSeq Project.

Ann Intern Med. 2017 Jun 27;167(3):159-169. doi: 10.7326/M17-0188. Print 2017 Aug 1.

25.

Prescription medication changes following direct-to-consumer personal genomic testing: findings from the Impact of Personal Genomics (PGen) Study.

Carere DA, VanderWeele TJ, Vassy JL, van der Wouden CH, Roberts JS, Kraft P, Green RC.

Genet Med. 2017 May;19(5):537-545. doi: 10.1038/gim.2016.141. Epub 2016 Sep 22.

26.

Patients' perceived utility of whole-genome sequencing for their healthcare: findings from the MedSeq project.

Lupo PJ, Robinson JO, Diamond PM, Jamal L, Danysh HE, Blumenthal-Barby J, Lehmann LS, Vassy JL, Christensen KD, Green RC, McGuire AL; MedSeq Project team.

Per Med. 2016 Jan 1;13(1):13-20. Epub 2016 Jan 8.

27.

Appropriateness: A Key to Enabling the Use of Genomics in Clinical Practice?

Vassy JL, Bates DW, Murray MF.

Am J Med. 2016 Jun;129(6):551-3. doi: 10.1016/j.amjmed.2016.02.010. Epub 2016 Mar 8. No abstract available.

28.

NIH working group report-using genomic information to guide weight management: From universal to precision treatment.

Bray MS, Loos RJ, McCaffery JM, Ling C, Franks PW, Weinstock GM, Snyder MP, Vassy JL, Agurs-Collins T; Conference Working Group.

Obesity (Silver Spring). 2016 Jan;24(1):14-22. doi: 10.1002/oby.21381. Review. Erratum in: Obesity (Silver Spring). 2016 Mar;24(3):757.

29.

Are physicians prepared for whole genome sequencing? a qualitative analysis.

Christensen KD, Vassy JL, Jamal L, Lehmann LS, Slashinski MJ, Perry DL, Robinson JO, Blumenthal-Barby J, Feuerman LZ, Murray MF, Green RC, McGuire AL; MedSeq Project Team.

Clin Genet. 2016 Feb;89(2):228-34. doi: 10.1111/cge.12626. Epub 2015 Jul 7.

30.

How to know when physicians are ready for genomic medicine.

Vassy JL, Korf BR, Green RC.

Sci Transl Med. 2015 May 13;7(287):287fs19. doi: 10.1126/scitranslmed.aaa2401.

31.

Association of a 62 Variants Type 2 Diabetes Genetic Risk Score With Markers of Subclinical Atherosclerosis: A Transethnic, Multicenter Study.

Dauriz M, Porneala BC, Guo X, Bielak LF, Peyser PA, Durant NH, Carnethon MR, Bonadonna RC, Bonora E, Bowden DW, Florez JC, Fornage M, Hivert MF, Jacobs DR Jr, Kabagambe EK, Lewis CE, Murabito JM, Rasmussen-Torvik LJ, Rich SS, Vassy JL, Yao J, Carr JJ, Kardia SL, Siscovick D, O'Donnell CJ, Rotter JI, Dupuis J, Meigs JB.

Circ Cardiovasc Genet. 2015 Jun;8(3):507-15. doi: 10.1161/CIRCGENETICS.114.000740. Epub 2015 Mar 24.

32.

A systematic approach to the reporting of medically relevant findings from whole genome sequencing.

McLaughlin HM, Ceyhan-Birsoy O, Christensen KD, Kohane IS, Krier J, Lane WJ, Lautenbach D, Lebo MS, Machini K, MacRae CA, Azzariti DR, Murray MF, Seidman CE, Vassy JL, Green RC, Rehm HL; MedSeq Project.

BMC Med Genet. 2014 Dec 14;15:134. doi: 10.1186/s12881-014-0134-1.

33.

'Someday it will be the norm': physician perspectives on the utility of genome sequencing for patient care in the MedSeq Project.

Vassy JL, Christensen KD, Slashinski MJ, Lautenbach DM, Raghavan S, Robinson JO, Blumenthal-Barby J, Feuerman LZ, Lehmann LS, Murray MF, Green RC, McGuire AL.

Per Med. 2015;12(1):23-32.

34.

A one-page summary report of genome sequencing for the healthy adult.

Vassy JL, McLaughlin HM, MacRae CA, Seidman CE, Lautenbach D, Krier JB, Lane WJ, Kohane IS, Murray MF, McGuire AL, Rehm HL, Green RC.

Public Health Genomics. 2015;18(2):123-9. doi: 10.1159/000370102. Epub 2015 Jan 21. Erratum in: Public Health Genomics. 2015 Apr;18(3):191. McLaughlin, Heather L [corrected to McLaughlin, Heather M].

35.

Response to comment on Vassy et al. polygenic type 2 diabetes prediction at the limit of common variant detection. Diabetes 2014;63:2172-2182.

Vassy JL, Hivert MF, Dauriz M, Meigs JB.

Diabetes. 2014 Jul;63(7):e13. doi: 10.2337/db14-0449. No abstract available.

36.

Metabolite traits and genetic risk provide complementary information for the prediction of future type 2 diabetes.

Walford GA, Porneala BC, Dauriz M, Vassy JL, Cheng S, Rhee EP, Wang TJ, Meigs JB, Gerszten RE, Florez JC.

Diabetes Care. 2014 Sep;37(9):2508-14. doi: 10.2337/dc14-0560. Epub 2014 Jun 19.

37.

The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine.

Vassy JL, Lautenbach DM, McLaughlin HM, Kong SW, Christensen KD, Krier J, Kohane IS, Feuerman LZ, Blumenthal-Barby J, Roberts JS, Lehmann LS, Ho CY, Ubel PA, MacRae CA, Seidman CE, Murray MF, McGuire AL, Rehm HL, Green RC; MedSeq Project.

Trials. 2014 Mar 20;15:85. doi: 10.1186/1745-6215-15-85.

38.

Susceptibility to type 2 diabetes mellitus--from genes to prevention.

Hivert MF, Vassy JL, Meigs JB.

Nat Rev Endocrinol. 2014 Apr;10(4):198-205. doi: 10.1038/nrendo.2014.11. Epub 2014 Feb 18. Review.

39.

Polygenic type 2 diabetes prediction at the limit of common variant detection.

Vassy JL, Hivert MF, Porneala B, Dauriz M, Florez JC, Dupuis J, Siscovick DS, Fornage M, Rasmussen-Torvik LJ, Bouchard C, Meigs JB.

Diabetes. 2014 Jun;63(6):2172-82. doi: 10.2337/db13-1663. Epub 2014 Feb 11. Erratum in: Diabetes. 2018 Apr 18;:.

40.
41.

Can genetic information change patient behavior to reduce Type 2 diabetes risk?

Vassy JL.

Per Med. 2013 Jan 1;10(1). doi: 10.2217/pme.12.116. No abstract available.

42.

Genomic medicine in primary care: barriers and assets.

Vassy JL, Green RC, Lehmann LS.

Postgrad Med J. 2013 Nov;89(1057):615-6. doi: 10.1136/postgradmedj-2013-132093. No abstract available.

43.

An exploration of violence, mental health and substance abuse in post-conflict Guatemala.

Branas CC, Dinardo AR, Puac Polanco VD, Harvey MJ, Vassy JL, Bream K.

Health (Irvine Calif). 2013 May;5(5):825-833.

44.

Genetic susceptibility testing for chronic disease and intention for behavior change in healthy young adults.

Vassy JL, Donelan K, Hivert MF, Green RC, Grant RW.

J Community Genet. 2013 Apr;4(2):263-71. doi: 10.1007/s12687-013-0140-6. Epub 2013 Feb 24.

45.

Genotype prediction of adult type 2 diabetes from adolescence in a multiracial population.

Vassy JL, Dasmahapatra P, Meigs JB, Schork NJ, Magnussen CG, Chen W, Raitakari OT, Pencina MJ, Jamal SM, Berenson GS, Goodman E.

Pediatrics. 2012 Nov;130(5):e1235-42. doi: 10.1542/peds.2012-1132. Epub 2012 Oct 15.

47.

Personalized genetic risk counseling to motivate diabetes prevention: a randomized trial.

Grant RW, O'Brien KE, Waxler JL, Vassy JL, Delahanty LM, Bissett LG, Green RC, Stember KG, Guiducci C, Park ER, Florez JC, Meigs JB.

Diabetes Care. 2013 Jan;36(1):13-9. doi: 10.2337/dc12-0884. Epub 2012 Aug 28.

48.

Comparison of regional body composition and its relation with cardiometabolic risk between BMI-matched young and old subjects.

Lee Y, Shin H, Vassy JL, Kim JT, Cho SI, Kang SM, Choi SH, Kim KW, Park KS, Jang HC, Lim S.

Atherosclerosis. 2012 Sep;224(1):258-65. doi: 10.1016/j.atherosclerosis.2012.07.013. Epub 2012 Jul 16.

PMID:
22832005
49.

A genotype risk score predicts type 2 diabetes from young adulthood: the CARDIA study.

Vassy JL, Durant NH, Kabagambe EK, Carnethon MR, Rasmussen-Torvik LJ, Fornage M, Lewis CE, Siscovick DS, Meigs JB.

Diabetologia. 2012 Oct;55(10):2604-2612. doi: 10.1007/s00125-012-2637-7. Epub 2012 Jul 11.

50.

Efficacy and safety of ginsam, a vinegar extract from Panax ginseng, in type 2 diabetic patients: Results of a double-blind, placebo-controlled study.

Yoon JW, Kang SM, Vassy JL, Shin H, Lee YH, Ahn HY, Choi SH, Park KS, Jang HC, Lim S.

J Diabetes Investig. 2012 Jun 6;3(3):309-17. doi: 10.1111/j.2040-1124.2011.00185.x.

Supplemental Content

Loading ...
Support Center